USE OF IPRIFLAVONE TO REDUCE THE NUMBER OF CD8+ CELLS

摘要

The present invention relates to pharmaceutical composition suitable to decrease the number of CD8+ cells comprising as active ingredient 7-isopropoxyisoflavone in admixture with suitable inert, solid or liquid carriers and optionally with usual therapeutic additives and auxiliary agents. The pharmaceutical compositions according to the invention are prepared by known methods and are suitable for the treatment of human or animal subjects being in a condition where selective suppression of CD8+ lymphocytes is desirable.